Bassez et al. used scTCR-Seq technology to confirm the presence of clonotype expansion in patients after PD-1 inhibitor treatment, indicating a continuous antitumor immune response; tumor cells from patients with clonotype expansion are enriched in pathways such as cell death, proteolysis, and immune signal transduction.104. This evidence concerns the gene PDCD1 and neoplasm.